Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001847903-25-000156
Filing Date
2025-11-05
Accepted
2025-11-05 07:31:36
Documents
69
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnta-20250930.htm   iXBRL 10-Q 1660395
2 EX-31.1 a20250930exhibit311.htm EX-31.1 9301
3 EX-31.2 a20250930exhibit312.htm EX-31.2 9218
4 EX-32.1 a20250930exhibit321.htm EX-32.1 5230
5 EX-32.2 a20250930exhibit322.htm EX-32.2 5036
  Complete submission text file 0001847903-25-000156.txt   7206464

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20250930.xsd EX-101.SCH 38202
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnta-20250930_cal.xml EX-101.CAL 82743
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20250930_def.xml EX-101.DEF 217303
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20250930_lab.xml EX-101.LAB 605808
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20250930_pre.xml EX-101.PRE 416294
71 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20250930_htm.xml XML 916353
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40445 | Film No.: 251451784
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)